Tag: Moderna plans to develop a single vaccine against multiple respiratory viruses

Moderna plans to develop a single vaccine against multiple respiratory viruses

July 8, 2021

On the back of the stunning success of mRNA vaccines over the past year – slowly but surely against the global COVID-19 pandemic – biotechnology company Moderna, Inc. (Moderna) has announced human trials testing an mRNA influenza vaccine. Known as mRNA-1010, the test vaccine targets influenza lineages recommended by the World Health Organization (WHO) including […]

Continue Reading